Laboratory Centrifuges Market Size, Share & Trends Analysis Report By Type  (Benchtop Centrifuges, Floor-Standing Centrifuges), By Application (Microbiology, Genomics, Proteomics, Diagnostics, Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics, Academic and Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Global Laboratory Centrifuges Market Size & Trends

The global laboratory centrifuges market size was valued at USD 1.92 billion in 2024 and is projected to grow from USD 2.03 billion in 2025 to reach USD 2.85 billion by 2033, exhibiting a CAGR of 4.4% during the forecast period (2025-2033). 

A laboratory centrifuge is a specialized device used to separate substances of different densities within a liquid by spinning them at high speeds. This process, called centrifugation, applies centrifugal force to accelerate the separation of particles based on size, shape, and density. Laboratory centrifuges are widely used in medical, research, and industrial applications, such as blood sample separation, DNA extraction, and pharmaceutical development. They come in various types, including microcentrifuges, benchtop centrifuges, and ultracentrifuges, each designed for specific applications.

The global market is experiencing steady growth, driven by technological advancements, increasing research activities, and expanding diagnostic applications. The rising demand for high-speed and ultra-centrifuges across biotechnology, pharmaceutical, and clinical laboratories is fuelling market growth. Moreover, the growing prevalence of infectious diseases, cancer, and genetic disorders is driving the adoption of centrifuges in diagnostics, molecular biology, and proteomics research.

The market is also witnessing a shift towards smart and automated centrifuges, integrating AI, IoT, and cloud-based monitoring, enhancing efficiency, data management, and remote operation. Miniaturization and portable centrifuges are gaining traction, particularly in point-of-care testing and resource-limited settings, expanding accessibility.

Latest Trends

Adoption of smart centrifuges

The adoption of smart centrifuges is rising with AI, IoT, and automation, enabling real-time monitoring, predictive maintenance, and remote operation. These innovations improve efficiency, reduce downtime, and enhance data management, making them ideal for biopharma, diagnostics, and genomics.

• For instance, in October 2024, GEA showcased a GEA separator skid at the Rockwell Automation Inc. Automation Fair in Anaheim, California. The skid is integrated with Rockwell Automation's latest hardware and software, including FactoryTalk Optix, highlighting advancements in centrifuge control and digitalization. This marks a significant step in GEA and Rockwell Automation’s partnership, focusing on smart centrifuge solutions with enhanced automation and monitoring capabilities.

Such advancements in smart centrifuges are set to redefine separation technologies and innovation in biopharma, diagnostics, and research applications, boosting market growth.

Rise of high-speed & ultracentrifuges

The rise of high-speed and ultracentrifuges is a growing trend driven by the increasing demand for rapid and precise sample separation in genomics, proteomics, drug discovery, and biopharmaceutical manufacturing. These advanced centrifuges offer higher g-force, improved efficiency, and enhanced automation, making them essential for high-throughput research and clinical applications.

• For instance, in October 2024, Thermo Scientific launched the general-purpose X Pro Centrifuges, designed for high performance, power, and versatility. This series integrates innovative features to enhance efficiency across various laboratory applications, reinforcing Thermo Scientific’s commitment to advanced centrifuge solutions for clinical, research, and industrial use.

This trend is expected to revolutionize laboratory workflows, enhancing accessibility, efficiency, and real-time diagnostics across diverse healthcare and research settings.

Laboratory Centrifuges Market Drivers

Rising investments in research and development

An increased research and development expenditure leads to the demand for laboratory centrifuges, especially in biotechnology, pharmaceutical, and academic markets. High-quality centrifuges are required for sample preparation, separation, and testing by labs with rising global research expenditure, particularly in biotechnology and life sciences.

• For instance, in September 2023, The Minister of Health and Family Welfare, Government of India, initiated the Pharma MedTech Sector Research and Innovation Promotion Scheme, popularly known as PRIP. Under the scheme, the Department of Pharmaceuticals has submitted a PRIP plan with a projected budget of USD 598.89 million.

Expanding genomics & proteomics research

The expansion of genomics and proteomics research is driving demand for high-speed and ultracentrifuges in DNA/RNA extraction, protein isolation, and biomarker discovery. Advances in next-generation sequencing (NGS), personalized medicine, and drug development require precise centrifugation for sample preparation and purification.

• For instance, in October 2024, an article published in the National Library of Medicine highlighted the study on Bacillus coagulans B-768, emphasizing its role in bioprocessing, where centrifuges are essential for cell harvesting, protein purification, and metabolite extraction.

With the rise in biopharma and industrial biotech expansion, the demand for high-speed centrifuges grows, driving the market growth.

Market Restraining Factors

High equipment & maintenance costs

The high cost of laboratory centrifuges, including both initial investment and ongoing maintenance, remains a major barrier to market expansion. Advanced models, such as ultracentrifuges and floor-standing centrifuges, require significant capital expenditure, regular calibration, and costly repairs, increasing the total cost of ownership.

Moreover, specialized rotors, temperature controls, and automation features add to the financial burden. These expenses are particularly challenging for small and mid-sized laboratories, research institutions, and facilities in developing regions with limited budgets.

As a result, adoption rates remain constrained despite the rising demand for centrifugation in medical diagnostics, biotechnology, and pharmaceutical research.

Market Opportunity

Integration with IoT & cloud computing

The integration of IoT and cloud computing in centrifuges enables real-time monitoring, predictive maintenance, and remote diagnostics, enhancing efficiency and reducing downtime. This technology supports automated data logging and workflow optimization, boosting adoption in biopharma, diagnostics, and research labs amid increasing digital transformation.

• For instance, in January 2024, GEA introduced X Control, a next-gen centrifuge control system integrating IoT, cloud computing, and AI for real-time monitoring, predictive maintenance, and self-optimization. It enhances SCADA integration, process adaptability, and resource efficiency, accelerating the adoption of smart centrifuges in laboratories and industries.

Such integration of IoT and AI-driven automation is set to enhance efficiency, precision, and sustainability in centrifuges, creating market opportunities.

Regional Insights

North America: Dominant region with 38.04% market share

North America holds the dominant position in the global laboratory centrifuges market, driven by substantial R&D investments, a strong presence of pharmaceutical and biotechnology companies, and advanced laboratory infrastructure. The region benefits from the increasing demand for precision medicine, a rising number of diagnostic laboratories, and the widespread adoption of automation in laboratory workflows.

Moreover, government funding for life sciences research, a growing focus on personalized healthcare, and the rising incidence of chronic and infectious diseases further support market expansion. Strategic collaborations between research institutions and industry players continue to enhance technological advancements, reinforcing North America's market leadership.

Asia Pacific: Fastest growing region with the highest market CAGR

Asia-Pacific is poised to register the fastest CAGR, fueled by rising healthcare investments, increasing R&D activities in biotechnology and pharmaceuticals, and the rapid expansion of diagnostic laboratories. The growing prevalence of chronic and infectious diseases is driving demand for advanced laboratory technologies. Moreover, government initiatives aimed at strengthening healthcare infrastructure, rising academic research activities, and the growing presence of contract research organizations (CROs) and contract manufacturing organizations (CMOs) contribute to market growth.

Country Insights

• U.S. - The U.S. dominates the laboratory centrifuges market, which is driven by high R&D investments, technological advancements, and the expansion of key industry facilities. In June 2024, Thermo Fisher Scientific expanded its clinical research laboratory in Wisconsin to meet the rising demand for advanced lab solutions. This expansion enhances capabilities in clinical diagnostics, drug development, and molecular research, accelerating the adoption of laboratory centrifuges and supporting the country’s leadership in life sciences innovation.
• Germany - Germany is one of the largest markets for laboratory centrifuges in Europe, driven by the rising investments and mergers and acquisitions among key players. For instance, in January 2024, Hettich Group acquired Philipp Kirsch GmbH, a Germany-based manufacturer of high-quality cooling and freezing solutions for laboratories and healthcare, as part of its strategic expansion. This acquisition strengthens Hettich’s position in the laboratory equipment market, enhancing its portfolio of centrifuges and complementary lab solutions.
• UK - In the UK, market growth is propelled by facility expansions and strategic investments by major industry players. In July 2024, Danaher announced the establishment of two new laboratories to advance companion and complementary diagnostics, including one in the UK, to support pharma and academic collaborations. This expansion boosts demand for centrifuges in biomarker discovery, sample processing, and clinical research, reinforcing the UK's role in precision medicine and driving innovation in the market.
• India - India’s laboratory centrifuges market is expanding due to rising domestic manufacturing capabilities and the launch of innovative products. In June 2024, Chennai-based VFL Sciences introduced the GreatSpin range of centrifuges, marking its entry into the market. This launch highlights the growing demand for advanced centrifuges in diagnostics, research, and biopharmaceutical applications. Moreover, government initiatives promoting biotech research and healthcare advancements are further propelling market growth across the country.
• China – China’s laboratory centrifuges market is emerging as a major force, driven by rapid industrialization, increasing healthcare expenditure, and a growing biotechnology and pharmaceutical sector. The country’s emphasis on precision medicine and diagnostics research fuels demand for advanced centrifuges. Moreover, government initiatives to enhance healthcare infrastructure, boost biomedical R&D, and expand life sciences research are accelerating market growth, positioning China as a key player.
• Japan– Japan’s laboratory centrifuges market is experiencing strong growth, supported by government-backed biomedical research, advancements in regenerative medicine, and a well-established pharmaceutical industry. The country's focus on genomics, proteomics, and personalized medicine is increasing demand for high-speed and ultracentrifuges. Moreover, the rising prevalence of chronic diseases and the need for cutting-edge clinical diagnostics continue to drive investments in laboratory centrifuges, solidifying Japan’s position as a leader.

Segmentation Analysis

The global laboratory centrifuges market is segmented into type, application, and end-user.

By Type

Benchtop centrifuges hold the largest market share due to their compact design, affordability, and versatility across clinical diagnostics, research laboratories, and biotech applications. Their ease of use, lower maintenance costs, and suitability for low- to medium-throughput applications make them highly preferred.

• For instance, in November 2024, Thermo Fisher Scientific introduced a high-capacity yet compact benchtop centrifuge, catering to the growing demand for space-efficient, high-performance solutions.

By Application

The diagnostics segment leads the market due to the essential role of centrifugation in blood testing, disease detection, and clinical sample processing. The rising prevalence of infectious diseases, cancer, and genetic disorders continues to drive demand for high-speed and automated centrifuges, improving workflow efficiency. Technological advancements, such as enhanced automation and faster processing speeds, further support the growing need for precise and rapid diagnostic solutions, making diagnostics a key driver of market expansion.

By End-User

Hospitals and clinics represent the largest end-user segment for laboratory centrifuges, driven by the growing demand for clinical diagnostics, disease screening, and blood testing. The increasing incidence of chronic diseases, rising patient admissions, and expanding diagnostic laboratory networks contribute to market growth. Moreover, advancements in automated centrifuge technology enhance efficiency, reducing turnaround times for critical tests. As healthcare facilities prioritize precision and speed in diagnostics, the adoption of centrifuges in hospital-based labs continues to rise, further solidifying this segment's dominance.

Company Market Share

Key players in the industry are focusing on adopting key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a strong foothold in the market. Companies are also investing in R&D to introduce advanced centrifuge technologies with enhanced automation, higher efficiency, and improved safety features.

Eppendorf AG: An emerging player in the global market

Eppendorf is a leading market competitor in the laboratory centrifuges market, particularly in the biotechnology and life sciences. With fame comes reliable, high-quality lab equipment production. The company has also introduced several innovative technologies, including a range of small and microcentrifuges.

Recent developments at Eppendorf AG include:

• In July 2023, Eppendorf's very innovative Centrifuge 5427 R, engineered with the latest hydrocarbon cooling technology, revolutionized laboratory techniques. Focusing on sustainable science, this microcentrifuge is designed to perform many molecular and cell biological applications.

Recent Developments

• November 2024 – OHAUS launched the Frontier™ FC5917RF, a high-performance large-capacity refrigerated centrifuge designed to cater to the evolving needs of modern laboratories. This advanced model offers enhanced speed, precise temperature control, and versatile rotor configurations, making it ideal for a wide range of applications, including clinical diagnostics, biotechnology, and pharmaceutical research.

Analyst Opinion

As per our analysts, the global laboratory centrifuges market is poised for substantial growth, driven by advancements in automation, increasing demand for high-throughput sample processing, and expanding applications in diagnostics, biotechnology, and pharmaceutical research. The integration of AI, IoT, and cloud computing into smart centrifuges is revolutionizing efficiency, enabling real-time monitoring, predictive maintenance, and enhanced data analytics.

Moreover, the surge in genomic and proteomic research, rising biopharmaceutical R&D investments, and the growing number of diagnostic laboratories are fueling market expansion. Emerging markets, particularly in the Asia-Pacific region, present significant opportunities due to rapid healthcare infrastructure development, increasing government support for life sciences research, and accelerated adoption of advanced laboratory technologies.

However, despite these growth drivers, the market faces challenges such as high equipment and maintenance costs, stringent regulatory requirements, and budget constraints in small and mid-sized laboratories. Moreover, operational complexities and the need for skilled personnel may hinder widespread adoption. Nonetheless, continuous technological innovations, strategic collaborations, and increasing automation are expected to mitigate these challenges, ensuring steady market progression in the coming years.